Previous Article | Next Article 
Molecular and Cellular Biology, December 2001, p. 8329-8335, Vol. 21, No. 24
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8329-8335.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Loss of mRor1 Enhances the Heart and Skeletal
Abnormalities in mRor2-Deficient Mice: Redundant and
Pleiotropic Functions of mRor1 and mRor2 Receptor Tyrosine
Kinases
Masashi
Nomi,1
Isao
Oishi,1
Shuichi
Kani,1
Hiroaki
Suzuki,1
Takeru
Matsuda,1
Akinori
Yoda,1
Makiko
Kitamura,2
Kyoko
Itoh,2
Shigeto
Takeuchi,1
Kiyoshi
Takeda,3
Shizuo
Akira,3
Makoto
Ikeya,4,
Shinji
Takada,4,5 and
Yasuhiro
Minami1,*
Department of Genome Sciences1 and
Department of Biomedical Informatics,2
Kobe University, Graduate School of Medicine, Kobe 650-0017, Department of Host Defense, Research Institute for Microbial
Diseases, Osaka University, Suita, Osaka
565-0871,3 Center for Molecular and
Developmental Biology, Graduate School of Science, Kyoto
University, Sakyo-ku, Kyoto 606-8502,4 and
Kondoh Differentiation Signalling Project, ERATO
(Exploratory Research for Advanced Technology) of Japan Science and
Technology Corporation (JST), Sakyo-ku, Kyoto
606-8305,5 Japan
Received 25 June 2001/Accepted 10 September 2001
 |
ABSTRACT |
The mammalian Ror family of receptor tyrosine kinases
consists of two structurally related proteins, Ror1 and Ror2. We have shown that mRor2-deficient mice exhibit widespread
skeletal abnormalities, ventricular septal defects in the heart, and
respiratory dysfunction, leading to neonatal lethality (S. Takeuchi, K. Takeda, I. Oishi, M. Nomi, M. Ikeya, K. Itoh, S. Tamura, T. Ueda, T. Hatta, H. Otani, T. Terashima, S. Takada, H. Yamamura, S. Akira,
and Y. Minami, Genes Cells 5:71-78, 2000). Here we show that
mRor1-deficient mice have no apparent skeletal or
cardiac abnormalities, yet they also die soon after birth due to
respiratory dysfunction. Interestingly, mRor1/mRor2 double mutant mice show
markedly enhanced skeletal abnormalities compared with
mRor2 mutant mice. Furthermore, double mutant mice also
exhibit defects not observed in mRor2 mutant mice,
including a sternal defect, dysplasia of the symphysis of the pubic
bone, and complete transposition of the great arteries. These results
indicate that mRor1 and mRor2 interact
genetically in skeletal and cardiac development.
 |
INTRODUCTION |
Receptor tyrosine kinases
(RTKs) play several crucial roles in developmental morphogenesis,
regulating cellular proliferation, differentiation, and migration, as
well as survival and death (26, 30). The Ror family RTKs
are a recently identified family of orphan RTKs, characterized by the
presence of extracellular Frizzled-like cysteine-rich domains and
membrane-proximal Kringle domains, both of which are assumed to mediate
protein-protein interactions (15, 20, 24, 25, 29). The Ror
family RTKs are evolutionarily conserved among Caenorhabditis
elegans, Drosophila, mice, and humans (7, 14, 19,
20, 34). Pairs of structurally similar Ror family RTKs are found
in Drosophila and mammals: Dror and Dnrk in Drosophila
melanogaster, Ror1 and Ror2 in humans, and mRor1 and mRor2 in
mice. Although it has been reported that CAM-1, a C. elegans
ortholog of the Ror family RTKs, plays several important roles in
regulating cellular migration, polarity of asymmetric cell divisions,
and axonal outgrowth of neurons during nematode development
(7), the functional and developmental roles of the
mammalian Ror family RTKs remain largely elusive.
The spatial and temporal expression of mRor1 and
mRor2 mostly overlap and are detected in the face, limbs,
heart, and lungs during mouse embryogenesis (16). These
expression patterns suggest that mRor1 and mRor2
may interact to play a role in the development of these organs. It has
been shown that mice lacking mRor2 expression exhibit
dwarfism, short limbs (with mesomelic dysplasia) and tail, facial
anomalies, ventricular septal defect (VSD), and respiratory dysfunction, ultimately leading to neonatal lethality (5,
32). Histological analyses of the skeletal systems reveal that
mRor2 plays a crucial role in the proliferation, differentiation,
maturation, and motility of chondrocytes (5, 32).
Interestingly, it has recently been reported that mutations within
Ror2 can cause the autosomal recessive Robinow syndrome or
autosomal dominant brachydactyly type B in humans (1, 21, 31,
33), further emphasizing essential roles of Ror2 in
morphogenetic and developmental processes. However, little is known
about the function of mRor1 during mouse development.
In order to elucidate the functional and developmental roles of
mRor1, we generated mice lacking a functional mRor1 gene by targeted gene disruption. mRor1
/
mice
died within 24 h after birth, presumably due to respiratory dysfunction. However, unlike the mRor2
/
mice, they did not exhibit any obvious morphological abnormalities of
the skeleton or heart. Given that the spatiotemporal expression patterns of mRor1 and mRor2 mostly overlap during
development (16), we investigated whether the loss of
mRor1 function can be compensated for by mRor2 in
mRor1
/
mice. To determine whether
mRor1 interacts genetically with mRor2 during
mouse development, we generated mRor1/mRor2
double mutants. Interestingly, the double mutants exhibited defects in
the skeletal and cardiac systems similar to but more severe than those
observed in the single mRor2 mutants. Furthermore, the
double mutant mice exhibited several defects not found in either the
mRor1 or mRor2 single mutants, namely, defects in
the sternum, dysplasia of the symphysis of the public bone, and
complete transposition of the great arteries. Analyses of these mutant
mice indicate that mRor1 and mRor2 are functionally redundant and that
mRor1 and mRor2 interact genetically in skeletal
and cardiac development.
 |
MATERIALS AND METHODS |
Preparation of mRor1 and
mRor1/mRor2 mutants.
Genomic DNA
containing the mRor1 locus was isolated from a genomic
library of mouse strain 129 (Stratagene). The exon of the mRor1 gene, containing an immunoglobulin (Ig)-like domain,
was replaced by the neo gene, and the herpes simplex virus
thymidine kinase gene was fused to the 5' end. The targeting vector was inserted into the E14 line of embryonic stem cells by electroporation, and homologous recombinants were selected by G418 and ganciclovir and
identified by PCR and Southern blot analysis. Targeted embryonic stem
cells were injected into blastocysts of C57BL/6 mice. The chimeras were
mated with C57BL/6 mice, and the mRor1 mutation was
transmitted to the germ line. The generation of mRor2 mutant mice has been described (32).
mRor1/mRor2 double mutants were generated by
intercrossing mRor1+/
;
mRor2+/
mice, and the embryos were
genotyped by PCR analysis of extraembryonic membranes.
Whole-mount in situ hybridization.
In situ hybridization
analyses of whole-mount embryos were performed as previously described
(35). The 0.7-kb PstI/KpnI fragment
of mRor1 or the 0.86-kb KpnI/NotI
fragment of mRor2 was utilized as a template to synthesize
single-strand RNA probes.
Histological analysis.
Embryos and newborns were fixed with
4% paraformaldehyde, dehydrated, embedded in wax, sectioned, and
processed for hematoxylin-and-eosin staining as described previously
(17).
Skeletal preparation.
Skeletal specimens were prepared
as described previously (12, 23) with minor modifications.
In brief, newborn mice were eviscerated, fixed in 100% ethanol for
24 h, and transferred to acetone. After 24 h, they were
rinsed with water and stained for 4 to 6 h at 37°C and for
24 h at room temperature in a staining solution consisting of 1 volume of 0.2% Alizarin red S (Sigma) in 95% ethanol, 1 volume of
0.3% Alcian blue 8GX (Sigma) in 70% ethanol, 1 volume of 100% acetic
acid, and 17 volumes of ethanol. The specimens were treated with 1%
trypsin in 30% saturated sodium borate solution at 37°C until ribs
became clear and then in 1% KOH at room temperature. After several
rinses with distilled water, the specimens were kept in 20% glycerol
at room temperature.
 |
RESULTS AND DISCUSSION |
To elucidate the functions of mRor1, we generated mice
lacking the exon of mRor1 containing the Ig-like domain
(Fig. 1A). Heterozygous
mRor1+/
mice were viable and fertile and
appeared normal. Heterozygous mice were crossed to produce wild-type,
heterozygous, and homozygous mutant mice, as assessed by genotyping
using Southern blot and PCR analyses (Fig. 1B and data not shown). The
mRor1
/
newborns were similar in size to
the wild-type mice and showed no apparent gross abnormalities (Fig.
1C). However, after birth, mRor1
/
mice
exhibited forced respiration and cyanosis and died within 24 h
(data not shown). In contrast, mRor2
/
newborns exhibited dwarfism, short limbs and tail, and malformation of
facial structures (Fig. 1C).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Targeted disruption of the
mRor1 gene. (A) Targeting strategy. The wild-type
mRor1 locus, targeting vector, and predicted mutant
locus are shown. The exon (including the Ig-like domain),
PGK-tk, and PGK-neo are depicted as open boxes. B,
BamHI; E, EcoRI; H,
HincII; HSV-tk, herpes simplex virus thymidine kinase.
(B) Southern blot analysis of fetal DNA. Genomic DNA isolated from yolk
sacs of embryos was digested with EcoRV and
HincII and hybridized with the
EcoRI-HincII probe shown in panel A. Sizes of bands are in kilobases. (C) Gross appearance of wild-type (WT)
and mutant newborns. While the mRor1 /
newborn looks essentially identical to the WT newborn, the
mRor2 / newborn is small and cyanotic and
has short limbs and tail. Enhancement of
mRor2 / phenotypes is observed in
mRor1 / ;
mRor2 / newborns.
|
|
Since mRor1
/
newborns died
apparently as a result of respiratory dysfunction, similar to
mRor2
/
mice, we performed a
histological examination of their lungs. Expansion of the alveoli in
mRor1 and mRor2 mutant newborns was found to be
incomplete, while the lungs of the wild-type newborns displayed
normally expanded alveoli (Fig. 2),
suggesting that mRor1 and mRor2 mutants die due
to difficulty in breathing. Since both mRor1 and
mRor2 are expressed in primitive alveoli in the developing
lung (16), mRor1 and/or mRor2 may play important roles in
the development and function of alveolar type II cells, which produce
dipalmitoylphosphatidylcholine (DPPC) and surfactant proteins (9,
13). However, expression levels of the surfactant protein genes
SP-A, -B, -C, and -D in the
lungs and the amounts of DPPC in bronchoalveolar lavage fluid from
mRor1 and mRor2 mutant newborns were comparable
to those of their wild-type littermates, as assessed by Northern blot
and gas chromatographic analyses, respectively (M. Nomi, Y. Kuroki, and
Y. Minami, unpublished data). Thus, the development and function of
alveolar type II cells is unaffected in the absence of mRor1
or mRor2. Further study is required to clarify the molecular
or cellular basis underlying pulmonary dysfunction in these mutant mice
and to understand the functional roles of mRor1 and mRor2 during lung
development.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
Histological analysis of the lung. Respiratory
malfunction was identified in mRor1 / and
mRor2 / newborns. Postmortem histological
analysis of the lung demonstrates that the alveolar air sacs in the
mutant newborns are not fully expanded as they are in the wild-type
(WT) control littermate. In addition, pulmonary bleeding was observed
in the mutant mice.
|
|
Although severe skeletal and cardiac phenotypes were found in
mRor2
/
mice,
mRor1
/
mice did not exhibit any
apparent abnormalities of the skeleton or heart (see below). Since
mRor1 and mRor2 exhibited similar expression
patterns in the developing face, limbs, heart, and lungs
(16), the lack of apparent abnormalities in the
mRor1
/
mice may be attributable to the
functional redundancy between mRor1 and mRor2. Given the more severe
phenotypes in mRor2
/
mice than in
mRor1
/
mice, we also considered that
expression of mRor1 may be down-regulated in
mRor2
/
mice. However, our in situ
hybridization analyses of mRor2
/
and
mRor1
/
embryos at day 10.5 of
development (E10.5) revealed that the spatial expression pattern
and level of mRor1 are unaffected by disruption of
mRor2 and vice versa (data not shown).
To determine whether mRor1 interacts genetically with
mRor2 during morphogenesis, we generated
mRor1/mRor2 double mutants by intercrossing
mRor1+/
;
mRor2+/
mice. The
mRor1/mRor2 mice exhibited perinatal lethality,
and, indeed, most if not all newborns were dead upon birth. Although mRor1
/
mice appeared to be essentially
identical to wild-type mice, mRor1/mRor2 mice
exhibited enhanced mRor2
/
phenotypes
(Fig. 1C). The shortening of limb and tail length in proportion to body
length and malformation of the facial structures observed in
mRor2
/
mice were more profound in the
double mutant mice, indicating that mRor1 and
mRor2 interact genetically during embryonic morphogenesis.
To examine more precisely the defects in limbs and body length of
mRor1/mRor2 double mutants, we next compared
skeletons from wild-type, mRor1
/
, and
mRor2
/
newborns and double mutant
embryos (E19.5) and newborns by staining with Alizarin red and Alcian
blue. It has been shown that mRor2
/
mice have abnormally short limbs and tails and abnormal vertebrae and
facial structures and that these defects are more severe in the more
distal portions (5, 32) (Fig.
3 and 4).
mRor2
/
mice also possess a unique
anomaly characterized by mesomelic dysplasia (significant or complete
loss of the radius, ulna, tibia, and fibula). Consistent with their
gross appearance, mRor1
/
newborns did
not show any skeletal abnormalities (Fig. 3 and 4). Interestingly, the
mRor1/mRor2 double mutant mice exhibited a
drastic enhancement of the mRor2
/
skeletal phenotypes (Fig. 3 and 4). Compared with
mRor2
/
mice, more severe hypoplasia of
the maxilla and mandible was found in the double mutant mice (Fig. 3C
and D). Importantly, dysplasia of the proximal long bones (the humerus
and femur), in addition to the distal long bones (mesomelic bones), was
observed in the double mutant mice (Fig. 3H and I). Significantly, the mRor1/mRor2 mice exhibited a sternal defect
(sternal agenesis) and dysplasia of the symphysis of the pubic bone,
skeletal abnormalities that were not observed in
mRor2
/
mice (Fig. 4D and H). These
results indicate that mRor1 and mRor2 are functionally redundant in the
development of the skeletal system and that mRor2 can compensate for
the lack of mRor1 function in mRor1
/
mice. Our observation that mutation of mRor1 in an
mRor2
/
background caused enhanced
skeletal defects as well as additional new phenotypes further indicates
the genetic interaction of mRor1 and mRor2 during
development.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
Examination of craniofacial bones and appendicular
skeletons. The craniofacial bones and appendicular skeletons from
wild-type (WT), mRor1 / , and
mRor2 / newborns and double mutant
embryos (E19.5) were double stained with Alizarin red and Alcian blue
as described in Materials and Methods. Lateral views of the skeleton of
the head (A to D) and extremities (forelimb [E to H] and hind limb
[I to L]) from wild-type and mutant newborns and a double mutant
embryo are shown. Asterisks and arrowheads, dysplasia of the distal and
proximal parts of limb bones in
mRor2 / and double mutant mice,
respectively. In some cases, apparently delayed ossification of the
cranial suture was also observed (data not shown).
|
|

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 4.
Examination of ribs, sternal bone, vertebrae, and pelvic
bones. The skeletons in wild-type (WT)and mutant newborns and double
mutant embryos were double stained with Alizarin red and Alcian blue.
Lateral (A to D), ventral (E to H), and dorsal (I to L) views are
shown. Arrow and arrowhead, sternal defect (D) and dysplasia of the
symphysis of the pubic bone (H) in
mRor1/mRor2 mice, respectively. The
sternal defect and dysplasia of the symphysis of the pubic bone were
observed in 100% (four of four) and 25% (one of four) of the double
mutant mice.
|
|
Dysplasia of the distal long bones in
mRor2
/
mice and of both the distal and
proximal long bones in mRor1/mRor2 double mutant mice suggests that mRor2 alone or in collaboration with mRor1 may
contribute to the compartmentalization of the appendicular skeletons.
It has been shown that the radius and ulna are almost completely
missing in hoxa-11, hoxd-11 double mutant
mice (4). In this respect, it will be of interest to
examine the possible relationships of mRor1 and
mRor2 with hoxa-11, hoxd-11, and other hox family genes. As described above, several unique
skeletal abnormalities were observed in
mRor1/mRor2 mice, including a sternal defect and
dysplasia of the symphysis of the pubic bone. Since it has been
reported that a subset of transgenic mice with aberrant expression of
hoxd-12 exhibit similar sternal defects as well as
abnormalities in the pelvis (11), we should also consider the possible relationship of mRor1 and mRor2 with
hoxd-12. Previous histological analyses of the long bones
from mRor2
/
mice have shown that they
have fewer small flattened chondrocytes and exhibit disarranged and
short longitudinal columns of proliferative chondrocytes in the zones
of proliferation and maturation, suggesting that mRor2 is required for
the proper proliferation, differentiation, maturation, and motility of
chondrocytes (5, 32). Our histological analyses of the
long bones from double mutant mice revealed essentially identical
results (data not shown), although further study will be required to
understand the roles of mRor1 and mRor2 in growth plate expansion.
mRor2 mutant newborns exhibited VSD (Fig.
5C) but no other abnormalities of the
heart, i.e., malformation of valves, aortic arch, and great vessels
(32) (data not shown). Our histological survey did not
reveal any apparent abnormalities in the hearts of
mRor1
/
mice (Fig. 5B). Intriguingly, in
addition to VSD, mRor1/mRor2 double mutant
embryos exhibited complete transposition of the great arteries (Fig. 5D
and E), a phenotype not observed in
mRor2
/
mice, indicating that
mRor1 and mRor2 interact genetically in regulating the development of the cardiovascular system. Transposition of the great vessels occurs when the conotruncal septum fails to follow
its normal spiral course and runs straight down (28). This
condition is frequently associated with a defect in the membranous part
of the interventricular septum, as observed in
mRor1/mRor2 double mutant mice. It has also been
reported that both transposition of the great arteries and VSD are
found in mice deficient in the type IIB activin receptor or endothelin
A receptor (2, 18). It will be of interest to test whether
mRor1 and/or mRor2 interact functionally with these receptors. It has
been shown that neural crest cells play two major roles in
cardiovascular patterning: they participate in the patterning of the
pharyngeal arches and their derivatives, including the aortic arch
arteries, and they migrate into the cardiac outflow tract and
participate in the formation of the outflow septum (10, 22,
27). It should be noted that both the mRor1 and
mRor2 genes are expressed in neural crest cells
(16). Therefore, we envisage that mRor2 and mRor1 play
important roles in the migration and function of the neural crest
cells, which in turn are required for proper formation of the
cardiovascular system. Genetic analyses have revealed that many
regulatory molecules are involved in cardiac development, including
looping effectors and septation effectors (8, 22). It will
be important to examine the possible relationships between these
regulatory molecules and the mRor proteins.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 5.
Histological analysis of hematoxylin-and-eosin-stained
longitudinal sections through hearts from wild-type (WT),
mRor1 / , and
mRor2 / newborns and a double mutant
embryo (E19.5). The hearts of mRor1 /
newborns exhibit no apparent abnormalities. Asterisks indicate cardiac
VSD in the mRor2 / newborn and the
mRor1 / ;
mRor2 / embryo (D) and the complete
transposition of the great arteries in the
mRor1 / ;
mRor2 / embryo (E). The complete
transposition of the great arteries with a situs solitus was observed
and was characterized by a discordant arterial connection, while the
atrioventricular connection was concordant (E) (3, 6).
Serial sections revealed that the pulmonary artery (PA) arising from
the left ventricle (LV) ran into the lung directly and that the aorta
(Ao) ran out from the right ventricle (RV) in the double mutant embryo
(data not shown). The spleen was found on the left side of the
abdominal cavity of the double mutant embryo, and neither situs
inversus nor asplenia was observed (data not shown). Bar, 300 µm.
|
|
Collectively, our findings help shed light on the roles of mRor1 and
mRor2 in developmental processes. mRor1 and mRor2 are functionally
redundant during cardiac and skeletal development, with mRor2 being
able to compensate for the functions of mRor1 in
mRor1
/
mice. On the other hand, both
mRor1 and mRor2 are required for the development and function of the
lung, since the absence of either mRor1 or mRor2
results in pulmonary dysfunction. Interestingly, the expression
patterns of mRor1 and mRor2 are essentially
identical in the developing lung (16). Furthermore,
preliminary results indicate that mRor1 and mRor2 interact physically
when both are expressed in cultured cells (A. Yoda, I. Oishi, and Y. Minami, unpublished data). Hence, the possible physical association of mRor1 and mRor2 may be important for normal lung development. Another
important conclusion drawn from this study is that mRor1 interacts genetically with mRor2 in the regulation of
cardiac and skeletal development, since both enhancement of the
mRor2
/
cardiovascular and skeletal
phenotypes and the severe phenotypes not observed in
mRor2
/
mice are found in
mRor1/mRor2 mice. Thus far, neither the ligands of mRor1 and mRor2 nor the cytoplasmic signaling molecules that associate with mRor1 and/or mRor2 have been identified. Identification and characterization of such molecules will facilitate our
understanding of the functional roles of mRor1 and mRor2 during development.
 |
ACKNOWLEDGMENTS |
We thank M. Lamphier for a critical reading of the manuscript.
This work was supported by a Research Grant for Cardiovascular
Diseases and a Research Grant for Comprehensive Research on Aging and
Health from the Ministry of Health and Welfare of Japan (Y.M.) and by
the Uehara Memorial Foundation (Y.M.), the Kowa Life Science Foundation
(Y.M.), the Yamanouchi Foundation for Research on Metabolic Disorders
(Y.M.), the Hyogo Science and Technology Association (I.O.), Nippon
Boehringer Ingelheim Co., Ltd., Kawanishi Pharma Research Institute
(Y.M.), and Daiichi Pharmaceutical Co., Ltd. (Y.M.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Genome Sciences (Division of Biomedical Regulation), Kobe University, Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. Phone: 81-78-382-5560. Fax: 81-78-382-5579. E-mail: minami{at}kobe-u.ac.jp.
Present address: Department of Medical Embryology and Neurobiology,
Institute for Frontier Medical Science, Kyoto University, Sakyo-ku,
Kyoto 606-8507, Japan.
 |
REFERENCES |
| 1.
|
Afzal, A. R.,
A. Rajab,
C. D. Fenske,
M. Oldridge,
N. Elanko,
E. Ternes-Pereira,
B. Tüysüz,
V. A. Murday,
M. A. Patton,
A. O. M. Wilkie, and S. Jeffery.
2000.
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of Ror2.
Nat. Genet.
25:419-422[CrossRef][Medline].
|
| 2.
|
Clouthier, D. E.,
K. Hosoda,
J. A. Richardson,
S. C. Williams,
H. Yanagisawa,
T. Kuwaki,
M. Kumada,
R. E. Hammer, and M. Yanagisawa.
1998.
Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice.
Development
125:813-824[Abstract].
|
| 3.
|
Colin, L. B.
1981.
Cardiac pathology, p. 87-145.
In
A. E. Becker, and R. H. Anderson (ed.), Paediatric pathology. Springer-Verlag, New York, N.Y.
|
| 4.
|
Davis, A. P.,
D. P. Witte,
H. M. Hsieh-Li,
S. S. Potter, and M. R. Capecchi.
1995.
Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11.
Nature
375:791-795[CrossRef][Medline].
|
| 5.
|
DeChiara, T. M.,
R. B. Kimble,
W. T. Poueymirou,
J. Rojas,
P. Masiakowski,
D. M. Valenzuela, and G. D. Yancopoulos.
2000.
Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development.
Nat. Genet.
24:271-274[CrossRef][Medline].
|
| 6.
|
Fanaroff, A. A., and R. J. Martin.
1987.
The cardiovascular system, p. 639-743.
In
M. H. Lees, and D. H. King (ed.), Neonatal-perinatal medicine. The C. V. Mosby Company, St. Louis, Mo.
|
| 7.
|
Forrester, W. C.,
M. Dell,
E. Perens, and G. Garriga.
1999.
C. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division.
Nature
400:881-885[CrossRef][Medline].
|
| 8.
|
Gilbert, S. F.
2000.
Lateral plate mesoderm and endoderm, p. 471-501.
In
S. F. Gilbert (ed.), Developmental biology, 6th ed. Sinauer Associates, Inc., Sunderland, Mass.
|
| 9.
|
Goerke, J.
1998.
Pulmonary surfactant: functions and molecular composition.
Biochim. Biophys. Acta
1408:79-89[Medline].
|
| 10.
|
Kirby, M. L., and K. L. Waldo.
1995.
Neural crest and cardiovascular patterning.
Circ. Res.
77:211-215[Free Full Text].
|
| 11.
|
Knezevic, V.,
R. De Santo,
K. Schughart,
U. Huffstadt,
C. Chiang,
K. A. Mahon, and S. Mackem.
1997.
Hoxd-12 differentially affects preaxial and postaxial chondrogenic branches in the limb and regulates Sonic hedgehog in a positive feedback loop.
Development
124:4523-4536[Abstract].
|
| 12.
|
Komori, T.,
H. Yagi,
S. Nomura,
A. Yamaguchi,
K. Sasaki,
K. Deguchi,
Y. Shimizu,
R. T. Bronson,
Y.-H. Gao,
M. Inada,
M. Sato,
R. Okamoto,
Y. Kitamura,
S. Yoshiki, and T. Kishimoto.
1997.
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.
Cell
89:755-764[CrossRef][Medline].
|
| 13.
|
Kuroki, Y., and D. R. Voelker.
1994.
Pulmonary surfactant proteins.
J. Biol. Chem.
269:25943-25946[Free Full Text].
|
| 14.
|
Masiakowski, P., and R. D. Carroll.
1992.
A novel family of cell surface receptors with tyrosine kinase-like domain.
J. Biol. Chem.
267:26181-26190[Abstract/Free Full Text].
|
| 15.
|
Masiakowski, P., and G. D. Yancopoulos.
1998.
The Wnt receptor CRD domain is also found in MuSK and related orphan receptor tyrosine kinases.
Curr. Biol.
8:R407[CrossRef][Medline].
|
| 16.
|
Matsuda, T.,
M. Nomi,
M. Ikeya,
S. Kani,
I. Oishi,
T. Terashima,
S. Takada, and Y. Minami.
2001.
Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development.
Mech. Dev.
105:153-156[CrossRef][Medline].
|
| 17.
|
Nagasawa, T.,
S. Hirota,
K. Tachibana,
N. Takakura,
S.-I. Nishikawa,
Y. Kitamura,
N. Yoshida,
H. Kikutani, and T. Kishimoto.
1996.
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
Nature
382:635-638[CrossRef][Medline].
|
| 18.
|
Oh, S. P., and E. Li.
1997.
The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse.
Genes Dev.
11:1812-1826[Abstract/Free Full Text].
|
| 19.
|
Oishi, I.,
S. Sugiyama,
Z.-J. Liu,
H. Yamamura,
Y. Nishida, and Y. Minami.
1997.
A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous system: unique structural features and implication in developmental signaling.
J. Biol. Chem.
272:11916-11923[Abstract/Free Full Text].
|
| 20.
|
Oishi, I.,
S. Takeuchi,
R. Hashimoto,
A. Nagabukuro,
T. Ueda,
Z.-J. Liu,
T. Hatta,
S. Akira,
Y. Matsuda,
H. Yamamura,
H. Otani, and Y. Minami.
1999.
Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system.
Genes Cells
4:41-56[Abstract].
|
| 21.
|
Oldridge, M.,
A. M. Fortuna,
M. Maringa,
P. Propping,
S. Mansour,
C. Pollitt,
T. M. DeChiara,
R. B. Kimble,
D. M. Valenzuela,
G. D. Yancopoulos, and A. O. M. Wilkie.
2000.
Dominant mutations in Ror2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B.
Nat. Genet.
24:275-278[CrossRef][Medline].
|
| 22.
|
Olson, E. N., and D. Srivastava.
1996.
Molecular pathways controlling heart development.
Science
272:671-676[Abstract].
|
| 23.
|
Otto, F.,
A. P. Thornell,
T. Crompton,
A. Denzel,
K. C. Gilmour,
I. R. Rosewell,
G. W. H. Stamp,
R. S. P. Beddington,
S. Mundlos,
B. R. Olsen,
P. B. Selby, and M. J. Owen.
1997.
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.
Cell
89:765-771[CrossRef][Medline].
|
| 24.
|
Patthy, L.,
M. Trexler,
Z. Vali,
L. Banyai, and A. Varadi.
1984.
Kringles: modules specialized for protein binding.
FEBS Lett.
171:131-136[CrossRef][Medline].
|
| 25.
|
Rehn, M.,
T. Pihlajaniemi,
K. Hofmann, and P. Bucher.
1998.
The frizzled motif: in how many different protein families does it occur?
Trends Biochem. Sci.
23:415-417[CrossRef][Medline].
|
| 26.
|
Robinson, D. R.,
Y.-M. Wu, and S.-F. Lin.
2000.
The protein tyrosine kinase family of the human genome.
Oncogene
19:5548-5557[CrossRef][Medline].
|
| 27.
|
Rossant, J.
1996.
Mouse mutants and cardiac development.
Circ. Res.
78:349-353[Abstract/Free Full Text].
|
| 28.
|
Sadler, T. W.
2000.
Cardiovascular system, p. 208-259.
In
T. W. Sadler (ed.), Langman's medical embryology. Lippincott Williams & Wilkins Co., Baltimore, Md.
|
| 29.
|
Saldanha, J.,
J. Singh, and D. Mahadevan.
1998.
Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases.
Protein Sci.
7:1632-1635[Medline].
|
| 30.
|
Schlessinger, J.
2000.
Cell signaling by receptor tyrosine kinases.
Cell
103:211-225[CrossRef][Medline].
|
| 31.
|
Schwabe, G. C.,
S. Tinschert,
C. Buschow,
P. Meinecke,
G. Wolff,
G. Gillessen-Kaesbach,
M. Oldridge,
A. O. M. Wilkie,
R. Kömec, and S. Mundlos.
2000.
Distinct mutations in the receptor tyrosine kinase gene Ror2 cause brachydactyly type B.
Am. J. Hum. Genet.
67:822-831[CrossRef][Medline].
|
| 32.
|
Takeuchi, S.,
K. Takeda,
I. Oishi,
M. Nomi,
M. Ikeya,
K. Itoh,
S. Tamura,
T. Ueda,
T. Hatta,
H. Otani,
T. Terashima,
S. Takada,
H. Yamamura,
S. Akira, and Y. Minami.
2000.
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation.
Genes Cells
5:71-78[Abstract].
|
| 33.
|
van Bokhoven, H.,
J. Celli,
H. Kayserili,
E. van Beusekom,
S. Balci,
W. Brussel,
F. Skovby,
B. Kerr,
E. F. Percin,
N. Akarsu, and H. G. Brunner.
2000.
Mutation of the gene encoding the Ror2 tyrosine kinase causes autosomal recessive Robinow syndrome.
Nat. Genet.
25:423-426[CrossRef][Medline].
|
| 34.
|
Wilson, C.,
D. C. I. Goberdhan, and H. Steller.
1993.
Dror, a potential neurotrophic receptor gene, encodes a Drosophila homolog of the vertebrate Ror family of Trk-related receptor kinases.
Proc. Natl. Acad. Sci. USA
90:7109-7113[Abstract/Free Full Text].
|
| 35.
|
Yoshikawa, Y.,
T. Fujimori,
A. P. McMahon, and S. Takada.
1997.
Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse.
Dev. Biol.
183:234-242[CrossRef][Medline].
|
Molecular and Cellular Biology, December 2001, p. 8329-8335, Vol. 21, No. 24
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8329-8335.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wilson, M. P., Hugge, C., Bielinska, M., Nicholas, P., Majerus, P. W., Wilson, D. B.
(2009). Neural tube defects in mice with reduced levels of inositol 1,3,4-trisphosphate 5/6-kinase. Proc. Natl. Acad. Sci. USA
106: 9831-9835
[Abstract]
[Full Text]
-
Baskar, S., Kwong, K. Y., Hofer, T., Levy, J. M., Kennedy, M. G., Lee, E., Staudt, L. M., Wilson, W. H., Wiestner, A., Rader, C.
(2008). Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia. Clin. Cancer Res.
14: 396-404
[Abstract]
[Full Text]
-
Liu, Y., Ross, J. F., Bodine, P. V. N., Billiard, J.
(2007). Homodimerization of Ror2 Tyrosine Kinase Receptor Induces 14-3-3{beta} Phosphorylation and Promotes Osteoblast Differentiation and Bone Formation. Mol. Endocrinol.
21: 3050-3061
[Abstract]
[Full Text]
-
Yamamoto, H., Yoo, S. K., Nishita, M., Kikuchi, A., Minami, Y.
(2007). Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.. GENES CELLS
12: 1215-1223
[Abstract]
[Full Text]
-
Liu, Y., Bhat, R. A., Seestaller-Wehr, L. M., Fukayama, S., Mangine, A., Moran, R. A., Komm, B. S., Bodine, P. V. N., Billiard, J.
(2007). The Orphan Receptor Tyrosine Kinase Ror2 Promotes Osteoblast Differentiation and Enhances ex Vivo Bone Formation. Mol. Endocrinol.
21: 376-387
[Abstract]
[Full Text]
-
Billiard, J., Way, D. S., Seestaller-Wehr, L. M., Moran, R. A., Mangine, A., Bodine, P. V. N.
(2005). The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells. Mol. Endocrinol.
19: 90-101
[Abstract]
[Full Text]
-
Forrester, W. C., Kim, C., Garriga, G.
(2004). The Caenorhabditis elegans Ror RTK CAM-1 Inhibits EGL-20/Wnt Signaling in Cell Migration. Genetics
168: 1951-1962
[Abstract]
[Full Text]
-
Kani, S., Oishi, I., Yamamoto, H., Yoda, A., Suzuki, H., Nomachi, A., Iozumi, K., Nishita, M., Kikuchi, A., Takumi, T., Minami, Y.
(2004). The Receptor Tyrosine Kinase Ror2 Associates with and Is Activated by Casein Kinase I{epsilon}. J. Biol. Chem.
279: 50102-50109
[Abstract]
[Full Text]
-
Matsuda, T., Suzuki, H., Oishi, I., Kani, S., Kuroda, Y., Komori, T., Sasaki, A., Watanabe, K., Minami, Y.
(2003). The Receptor Tyrosine Kinase Ror2 Associates with the Melanoma-associated Antigen (MAGE) Family Protein Dlxin-1 and Regulates Its Intracellular Distribution. J. Biol. Chem.
278: 29057-29064
[Abstract]
[Full Text]